Novel 3beta-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
申请人:Imbert Thierry
公开号:US20050080085A1
公开(公告)日:2005-04-14
The invention concerns compounds of general formula 1, wherein: A, B, D and E represent one or two nitrogen atoms, the others being carbon atoms; X represents a S or, a O, thereby forming a bicyclic fused heteroaromatic, such as thieno[2,3-b]pyridine, furo[2,3-b]pyridine, thieno[3,2-b]pyridine, furo[3,2-b]pyridine, thieno[2,3-b]pyrazine, furo[2,3-b]pyrazine, thieno[2,3-c]pyridine, furo[2,3-c]pyridine, thieno[3,2-c]pyridine and furo[3,2-c]pyridine; R1 represents a linear or branched C
1
-C
6
alkoxy group, a linear or branched C
1
-C
6
alkylthio group; R2 represents a linear, branched, cyclic C
2
-C
8
group, a 2- or 3- thienylmethyl group, or a benzyl group optionally substituted by one or several halogens, F, Cl, Br, I, C
1
-C
4
alkyl, C
1
-C
4
alkoxy, CF3, CN, NO2, OH; and their pharmaceutically acceptable salts. Said compounds are anti-dopaminergic agents.
该发明涉及一般式1的化合物,其中:A、B、D和E代表一个或两个氮原子,其他原子是碳原子;X代表S或O,从而形成一个双环融合的杂芳烃,如噻吩[2,3-b]吡啶、呋吩[2,3-b]吡啶、噻吩[3,2-b]吡啶、呋吩[3,2-b]吡啶、噻吩[2,3-b]吡嗪、呋吩[2,3-b]吡嗪、噻吩[2,3-c]吡啶、呋吩[2,3-c]吡啶、噻吩[3,2-c]吡啶和呋吩[3,2-c]吡啶;R1代表线性或支链的C1-C6烷氧基团,线性或支链的C1-C6烷硫基团;R2代表线性、支链、环状的C2-C8基团,2-或3-噻吩甲基基团,或一个苄基团,可选地被一个或几个卤素,F、Cl、Br、I、C1-C4烷基、C1-C4烷氧基、CF3、CN、NO2、OH取代;以及它们的药学上可接受的盐。所述化合物是抗多巴胺能作用剂。